Q&A: Postpartum depression drug heralds new hope for moms, says physician

The Food and Drug Administration announced Friday its approval of the new drug zuranolone for postpartum depression. The once-daily pill, meant for short-term use, may help those who struggle with the serious, sometimes life-threatening condition.